(Total Views: 619)
Posted On: 08/09/2021 4:47:47 PM
Post# of 154130
Re: Evil Rabbit #99404
No just just some realistic timeliness I've seen in other Biotech stocks I'm in and all the cancer studies I've read.
So Mrk's Keytruda the most successful cancer drug out there,$10B per year and climbing, has to do a P3 for each type of cancer even though it is a platform type cancer drug. But little old CYDY that has a great relationship with the FDA is just going to walk away in 6 months with a BTD and approval.
Could BTD push up approval yes, by how much we don't know.
So Mrk's Keytruda the most successful cancer drug out there,$10B per year and climbing, has to do a P3 for each type of cancer even though it is a platform type cancer drug. But little old CYDY that has a great relationship with the FDA is just going to walk away in 6 months with a BTD and approval.
Could BTD push up approval yes, by how much we don't know.
(3)
(1)
